Make your money go further for just 25p per day

Whopping contract | FDA approval | Another offer

02/11/2023 · Cerillion (CER) · Creo Medical (CREO) · Equals Group PLC (EQLS) · Oxford Metrics (OMG) · Premier Miton Group (PMI) · Sopheon

AIM AIM Inheritance Tax potential UK

Our free update here includes news of yet another significant contract win for a high-performing AIM software company. Elsewhere, two companies are starting to put their significant cash piles to hopefully better use with acquisitions, while yet another AIM company is under offer, this time for a big premium. Read on here for this and other news.

Cerillion secures another whopper

Cerillion (AIM:CER), the creator of software for billing, charging and customer relationship management, has announced another significant contract win to add further support to its lofty valuation.

Cerillion has signed a major new contract, worth an initial €12.4m, with a Tier-1 telecommunications provider, based in Europe.

Cerillion will be supplying and implementing the core elements of its flagship solution, including billing, charging, fulfilment and product catalogue, on…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Previous article Next article

More on Cerillion

Great results from software and (miraculously) fund management

19/11/2024 · Company Insights

News covered here includes our assessment of sparking results from a provider of software to the…

Excellent results, but nobody is looking!

21/10/2024 · Company Insights

If you need any encouragement that AIM is more than simply about tax planning, several companies…

More on Creo Medical

Episode 18 of the Investor’s Champion Podcast

18/05/2024 · Podcasts

In this episode of the Investor’s Champion Podcast Chris and Lee consider the recent highs of…

Innovators think big

15/05/2024 · Company Insights

It’s tough being an innovator, but should things develop as intended, the potential rewards can be huge.…

More on Equals Group PLC

Compelling value | Debt worries

16/01/2024 · Company Insights

News covered here include trading updates from two main market small caps, with one looking considerably more…

Whopping contract | FDA approval | Another offer

02/11/2023 · Company Insights

Our free update here includes news of yet another significant contract win for a high-performing AIM…

More on Oxford Metrics

Great results | Whopping contracts | Capital efficiency

06/12/2023 · Company Insights

A small company covered here has issued excellent results and sits on a very large cash…

Whopping contract | FDA approval | Another offer

02/11/2023 · Company Insights

Our free update here includes news of yet another significant contract win for a high-performing AIM…

More on Premier Miton Group

10% dividend yield | Another brand buy | Frasers falls

06/12/2024 · Company Insights

News covered here incudes our assessment of results from a lowly valued UK fund manager, whose…

Excellent travel companies | More fund manager appeal

15/07/2024 · Company Insights

News covered here includes our assessment of full year results from AIM’s largest company. With a…

More on Sopheon

Whopping contract | FDA approval | Another offer

02/11/2023 · Company Insights

Our free update here includes news of yet another significant contract win for a high-performing AIM…

Hidden value | Questionable cash flow

30/01/2023 · Company Insights

Updates from AIM covered here include the realisation of some hidden value in an engineering group, where…

More on Cerillion

Great results from software and (miraculously) fund management

Excellent results, but nobody is looking!

Another AIM takeover | Director buying | Good value?

Fabulous results | Legal eagles| Plenty to do

More on Creo Medical

Episode 18 of the Investor’s Champion Podcast

Innovators think big

Whopping contract | FDA approval | Another offer

Impairments | Dividend reinstatement | Bonkers Bargain

More on Equals Group PLC

Compelling value | Debt worries

Whopping contract | FDA approval | Another offer

Fintech finesse | Dividend hikes | Cash flow conundrums

Looking good | Puzzling valuations | Stonking Small Cap update

More on Oxford Metrics

Great results | Whopping contracts | Capital efficiency

Whopping contract | FDA approval | Another offer

Cash support | Strange departures | Bonkers Bargains

Stunning results | IHT qualification concerns

More on Premier Miton Group

10% dividend yield | Another brand buy | Frasers falls

Excellent travel companies | More fund manager appeal

Episode 21 of the Investor’s Champion Podcast

Big AIM dividend payers | Stonking Small Cap update

More on Sopheon

Whopping contract | FDA approval | Another offer

Hidden value | Questionable cash flow

The good and the puzzling!

Highly rated: can they deliver?

Insolvency solvency | Family fortunes | US delays

Mandate loss | Korean woes | AI investment

Important partners | Attractive valuation | Bonkers Bargains

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at c/o Cox Costello & Horne, Batchworth Lock House, 99 Church Street, Rickmansworth, WD3 1JJ.

All rights reserved. © 2007 - 2024